Wingrove Theresa's Form 4 filing
ImmunoGen, Inc. (IMGN) · filed Dec 19, 2023
- Accession no.
- 0001415889-23-016754
- Filed
- Dec 19, 2023
- Trade date
- Dec 15, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.45M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wingrove TheresaCIK 0001510720 | Officer (SVP OF REGULATORY AFFAIRS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Common Stock | MOption exerciseAcquired | +27,788 | $4.55 | +$126,435.4 | 30,599 | Direct | |
| Dec 15, 2023 | Common Stock | MOption exerciseAcquired | +89,657 | $5.32 | +$476,975.24 | 120,256 | Direct | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −117,445 | $29.40 | −$3,452,883 | 2,811 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Common Stock | MOption exerciseDisposed | −27,788 | $0.00 | $0 | 35,871 | Direct | |
| Dec 15, 2023 | Common Stock | MOption exerciseDisposed | −89,657 | $0.00 | $0 | 115,273 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.